ISPC
Price
$1.17
Change
-$0.17 (-12.78%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
9.61M
STXS
Price
$2.92
Change
-$0.00 (-0.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
267.74M
40 days until earnings call
Interact to see
Advertisement

ISPC vs STXS

Header iconISPC vs STXS Comparison
Open Charts ISPC vs STXSBanner chart's image
iSpecimen
Price$1.17
Change-$0.17 (-12.78%)
Volume$3.23K
Capitalization9.61M
Stereotaxis
Price$2.92
Change-$0.00 (-0.00%)
Volume$744
Capitalization267.74M
ISPC vs STXS Comparison Chart in %
Loading...
ISPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ISPC vs. STXS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISPC is a Hold and STXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ISPC: $1.17 vs. STXS: $2.94)
Brand notoriety: ISPC and STXS are both not notable
ISPC represents the Medical Specialties, while STXS is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ISPC: 15% vs. STXS: 30%
Market capitalization -- ISPC: $9.61M vs. STXS: $267.74M
ISPC [@Medical Specialties] is valued at $9.61M. STXS’s [@Pharmaceuticals: Other] market capitalization is $267.74M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.34B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ISPC’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • ISPC’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both ISPC and STXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ISPC’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 3 bullish TA indicator(s).

  • ISPC’s TA Score: 5 bullish, 5 bearish.
  • STXS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ISPC and STXS are a good buy in the short-term.

Price Growth

ISPC (@Medical Specialties) experienced а -17.02% price change this week, while STXS (@Pharmaceuticals: Other) price change was +4.63% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.53%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +24.99%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.53% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STXS($268M) has a higher market cap than ISPC($9.61M). STXS YTD gains are higher at: 28.947 vs. ISPC (-55.932). ISPC has higher annual earnings (EBITDA): -8.01M vs. STXS (-22.41M). STXS has more cash in the bank: 6.97M vs. ISPC (589K). ISPC has less debt than STXS: ISPC (288K) vs STXS (5.73M). STXS has higher revenues than ISPC: STXS (31.8M) vs ISPC (5.91M).
ISPCSTXSISPC / STXS
Capitalization9.61M268M4%
EBITDA-8.01M-22.41M36%
Gain YTD-55.93228.947-193%
P/E RatioN/AN/A-
Revenue5.91M31.8M19%
Total Cash589K6.97M8%
Total Debt288K5.73M5%
FUNDAMENTALS RATINGS
STXS: Fundamental Ratings
STXS
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ISPCSTXS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
89%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ISPC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY1.290.04
+3.20%
Oncolytics Biotech
HY37.141.03
+2.85%
Hyster-Yale Inc.
EIX55.010.96
+1.78%
Edison International
GEO20.90-0.02
-0.10%
GEO Group (The)
ATER1.02-0.03
-2.86%
Aterian